GSK IBS candidate (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK IBS candidate (investigational), covering 2017-05-08 to 2017-05-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers [Phase 1]